Legal & General Group PLC Nex Immune, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $848 - $24,745	-1,414 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$1.61 - $4.68 $449 - $1,305	-279 Reduced 16.48%	1,414 $2,000
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $11,042 - $18,083	1,070 Added 171.75%	1,693 $26,000
Q1 2021 May 17, 2021	BUY	$17.95 - $25.91 $11,182 - $16,141	623 New	623 $12,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $7.73M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.